RECURSION PHARMACEUTICALS, INC. — 4 Filings
438 4 filings on record
This page lists all 4 filings submitted to the SEC by RECURSION PHARMACEUTICALS, INC. (RXRX), sorted by most recent first. Each row links to the full filing on EdgarLookup. RECURSION PHARMACEUTICALS, INC. has filed 438 4 documents with the SEC since 2014. To view all SEC filings by RECURSION PHARMACEUTICALS, INC., see the full filings list.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
424B7
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PREM14A
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001601830-26-000052 | Mar 25, 2026 | Mar 23, 2026 |
| 4 | FORM 4 | 0001712276-26-000002 | Mar 18, 2026 | Mar 16, 2026 |
| 4 | FORM 4 | 0001601830-26-000049 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | FORM 4 | 0001601830-26-000048 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | FORM 4 | 0001601830-26-000045 | Mar 4, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001601830-26-000021 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000022 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000020 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000019 | Feb 19, 2026 | Feb 17, 2026 |
| 4 | FORM 4 | 0001601830-26-000014 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001601830-26-000012 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001601830-26-000013 | Feb 10, 2026 | Feb 6, 2026 |
| 4 | FORM 4 | 0001601830-26-000007 | Feb 6, 2026 | Feb 3, 2026 |
| 4 | FORM 4 | 0001601830-26-000008 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | FORM 4 | 0001856369-26-000005 | Jan 22, 2026 | Jan 20, 2026 |
| 4 | FORM 4 | 0001856094-26-000002 | Jan 8, 2026 | Jan 6, 2026 |
| 4 | FORM 4 | 0001856369-26-000003 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | FORM 4 | 0001852075-26-000002 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001837016-26-000003 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001712276-25-000017 | Dec 30, 2025 | Dec 29, 2025 |
| 4 | FORM 4 | 0001601830-25-000176 | Dec 29, 2025 | Dec 22, 2025 |
| 4 | FORM 4 | 0001856369-25-000018 | Dec 19, 2025 | — |
| 4 | FORM 4 | 0001712276-25-000015 | Dec 17, 2025 | Dec 15, 2025 |
| 4 | FORM 4 | 0001856369-25-000016 | Dec 5, 2025 | Dec 4, 2025 |
| 4 | FORM 4 | 0001856094-25-000006 | Dec 4, 2025 | Dec 2, 2025 |
| 4 | FORM 4 | 0001712276-25-000013 | Nov 26, 2025 | Nov 25, 2025 |
| 4 | FORM 4 | 0002020969-25-000006 | Nov 19, 2025 | Nov 17, 2025 |
| 4 | FORM 4 | 0001712276-25-000011 | Nov 19, 2025 | Nov 17, 2025 |
| 4 | FORM 4 | 0001856369-25-000014 | Nov 19, 2025 | Nov 17, 2025 |
| 4 | FORM 4 | 0001856369-25-000012 | Nov 6, 2025 | Nov 4, 2025 |
| 4 | FORM 4 | 0002020969-25-000004 | Nov 6, 2025 | Nov 5, 2025 |
| 4 | FORM 4 | 0001856369-25-000010 | Oct 24, 2025 | Oct 23, 2025 |
| 4 | FORM 4 | 0001856369-25-000007 | Oct 10, 2025 | — |
| 4 | FORM 4 | 0001837016-25-000005 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | FORM 4 | 0001852075-25-000005 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | FORM 4 | 0001856369-25-000005 | Sep 26, 2025 | Sep 25, 2025 |
| 4 | FORM 4 | 0001601830-25-000147 | Sep 17, 2025 | Sep 15, 2025 |
| 4 | FORM 4 | 0001601830-25-000145 | Sep 12, 2025 | Sep 10, 2025 |
| 4 | FORM 4 | 0001601830-25-000136 | Aug 28, 2025 | Aug 26, 2025 |
| 4 | FORM 4 | 0001601830-25-000133 | Aug 19, 2025 | Aug 15, 2025 |
| 4 | FORM 4 | 0001601830-25-000132 | Aug 19, 2025 | Aug 15, 2025 |
| 4 | FORM 4 | 0001601830-25-000131 | Aug 19, 2025 | Aug 15, 2025 |
| 4 | FORM 4 | 0001601830-25-000130 | Aug 13, 2025 | Aug 11, 2025 |
| 4 | FORM 4 | 0001601830-25-000115 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | FORM 4 | 0001601830-25-000116 | Jul 3, 2025 | Jul 1, 2025 |
| 4 | FORM 4 | 0001601830-25-000108 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001601830-25-000109 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001601830-25-000110 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001601830-25-000111 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | FORM 4 | 0001601830-25-000112 | Jun 23, 2025 | Jun 18, 2025 |